Net Zero for the Chemical Industry—Including Pharma—is Possible. But Only if We Act Now.

Is Net Zero by 2050 truly realistic for sectors like chemicals and pharmaceuticals? It is—but only if we stop waiting and start acting. The clock is ticking, and the primary chemical industry—responsible for producing ammonia, methanol, and high-value chemicals—cannot afford delay.

This isn’t just about basic chemicals—this industry also provides the essential building blocks for pharmaceuticals. Decarbonizing it means decarbonizing the foundation of modern medicine.

As pressure grows for greener supply chains, pharmaceutical companies—deeply reliant on chemical inputs—will face increasing scrutiny on their upstream emissions.

According to the IEA's Net Zero Roadmap, the sector must slash its emissions intensity from 1.27 Mt CO₂ per Mt of chemicals in 2023 to just 0.03 Mt CO₂ per Mt by 2050 in the Net Zero Scenario. This is noti ncremental progress—it’s a radical transformation. And it will only be possible through aggressive adoption of available low-emission technologies, coupled with systemic innovation.

The World Economic Forum’s 2024 Net-Zero Industry Tracker rightly emphasizes that the pathway hinges on "a rapid transition to low-emission technologies,including electrification, energy and process efficiency, carbon capture,utilization, and storage (CCUS), and the adoption of green hydrogen."

These are not hypothetical future solutions—they exist today, even if not yet at fullscale.

The industry faces a critical choice: wait for these technologies to mature, or act immediately with what's already within reach. Waiting is not a neutral decision—it’s a risk. Delaying action prolongs reliance on high-emission infrastructure, drives up future transition costs, and shrinks the window to achieve climate goals. Companies must adopt a dual approach: proactively invest in current low-emission solutions and set Science-Based Targets initiative (SBTi)-aligned goals for decarbonization, while planning for the integration of emerging technologies as they become viable.

It's encouraging to see pioneers in the sector begin to take steps—piloting green hydrogen, retrofitting plants with CCUS, improving process efficiency through digitalization. But pilot projects won’t carry us to Net Zero. We need full-scale deployment backed by bold leadership and policy certainty.

Let’s be clear: the 2050 goal is technically achievable. The question is whether the industry has the strategic courage to act before it's convenient. Net Zero by mid-century will only be a reality for the primary chemical sector if we decarbonize—not tomorrow, but today.

Organizations navigating this complex transition can accelerate results and don’t have to do it alone: at Positive Organizations we offer tailored support to companies in the pharmaceutical and industrial sectors, helping them design and implement effective decarbonization strategies. From setting SBTi-aligned targets to integrating advanced low-emission technologies and reporting frameworks, we provide the expertise needed to turn ambition into action—today, not in 2049.

‍

Looking for expert guidance? Explore our Science-based Decarbonization Plans and Pharma services to take the next step.

You may also be interested in: Science-Based Targets Initiative (SBTi): A Key Driver of Corporate Climate Action